INTRODUCTION: Male circumcision reduces HIV acquisition in men. We assessed whether foreskin surface area was associated with HIV acquisition prior to circumcision. METHODS: In two randomized trials of male circumcision, the surface area of the foreskin was measured after surgery using standardized procedures. Nine hundred and sixty-five initially HIV-negative men were enrolled in a community cohort who subsequently enrolled in the male circumcision trials, provided 3920.8 person-years of observation prior to circumcision. We estimated HIV incidenceper 100 person-years prior to circumcision, associated with foreskin surface area categorized into quartiles. RESULTS:Mean foreskin surface area was significantly higher among men who acquired HIV (43.3 cm2, standard error 2.1) compared with men who remained uninfected (36.8 cm, standard error 0.5, P = 0.01). HIV incidence was 0.80/100 person-years (8/994.9 person-years) for men with foreskin surface areas in the lowest quartile (< or =26.3 cm2), 0.92/100 person-years (9/975.3 person-years) with foreskin areas in the second quartile (26.4-35.0 cm2), 0.90/100 person-years (8/888.5 person-years) with foreskin area in the third quartile (35.2-45.5 cm2) and 2.48/100 person-years (23/926.8 person-years) in men with foreskin surfaces areas in the highest quartile (>45.6 cm2). Compared with men with foreskin surface areas in the lowest quartile, the adjusted incidence rate ratio of HIV acquisition was 2.37 (95% confidence interval 1.05-5.31) in men with the largest quartile of foreskin surface area. CONCLUSION: The risk of male HIV acquisition is increased among men with larger foreskin surface areas.
RCT Entities:
INTRODUCTION: Male circumcision reduces HIV acquisition in men. We assessed whether foreskin surface area was associated with HIV acquisition prior to circumcision. METHODS: In two randomized trials of male circumcision, the surface area of the foreskin was measured after surgery using standardized procedures. Nine hundred and sixty-five initially HIV-negative men were enrolled in a community cohort who subsequently enrolled in the male circumcision trials, provided 3920.8 person-years of observation prior to circumcision. We estimated HIV incidence per 100 person-years prior to circumcision, associated with foreskin surface area categorized into quartiles. RESULTS: Mean foreskin surface area was significantly higher among men who acquired HIV (43.3 cm2, standard error 2.1) compared with men who remained uninfected (36.8 cm, standard error 0.5, P = 0.01). HIV incidence was 0.80/100 person-years (8/994.9 person-years) for men with foreskin surface areas in the lowest quartile (< or =26.3 cm2), 0.92/100 person-years (9/975.3 person-years) with foreskin areas in the second quartile (26.4-35.0 cm2), 0.90/100 person-years (8/888.5 person-years) with foreskin area in the third quartile (35.2-45.5 cm2) and 2.48/100 person-years (23/926.8 person-years) in men with foreskin surfaces areas in the highest quartile (>45.6 cm2). Compared with men with foreskin surface areas in the lowest quartile, the adjusted incidence rate ratio of HIV acquisition was 2.37 (95% confidence interval 1.05-5.31) in men with the largest quartile of foreskin surface area. CONCLUSION: The risk of male HIV acquisition is increased among men with larger foreskin surface areas.
Authors: L Lavreys; J P Rakwar; M L Thompson; D J Jackson; K Mandaliya; B H Chohan; J J Bwayo; J O Ndinya-Achola; J K Kreiss Journal: J Infect Dis Date: 1999-08 Impact factor: 5.226
Authors: Jared M Baeten; Barbra A Richardson; Ludo Lavreys; Joel P Rakwar; Kishorchandra Mandaliya; Job J Bwayo; Joan K Kreiss Journal: J Infect Dis Date: 2005-01-18 Impact factor: 5.226
Authors: R H Gray; N Kiwanuka; T C Quinn; N K Sewankambo; D Serwadda; F W Mangen; T Lutalo; F Nalugoda; R Kelly; M Meehan; M Z Chen; C Li; M J Wawer Journal: AIDS Date: 2000-10-20 Impact factor: 4.177
Authors: Maria J Wawer; Frederick Makumbi; Godfrey Kigozi; David Serwadda; Stephen Watya; Fred Nalugoda; Dennis Buwembo; Victor Ssempijja; Noah Kiwanuka; Lawrence H Moulton; Nelson K Sewankambo; Steven J Reynolds; Thomas C Quinn; Pius Opendi; Boaz Iga; Renee Ridzon; Oliver Laeyendecker; Ronald H Gray Journal: Lancet Date: 2009-07-18 Impact factor: 79.321
Authors: Steven J Reynolds; Mary E Shepherd; Arun R Risbud; Raman R Gangakhedkar; Ronald S Brookmeyer; Anand D Divekar; Sanjay M Mehendale; Robert C Bollinger Journal: Lancet Date: 2004-03-27 Impact factor: 79.321
Authors: Bruce K Patterson; Alan Landay; Joan N Siegel; Zareefa Flener; Dennis Pessis; Antonio Chaviano; Robert C Bailey Journal: Am J Pathol Date: 2002-09 Impact factor: 4.307
Authors: Jason Bailey Reed; Emmanuel Njeuhmeli; Anne Goldzier Thomas; Melanie C Bacon; Robert Bailey; Peter Cherutich; Kelly Curran; Kim Dickson; Tim Farley; Catherine Hankins; Karin Hatzold; Jessica Justman; Zebedee Mwandi; Luke Nkinsi; Renee Ridzon; Caroline Ryan; Naomi Bock Journal: J Acquir Immune Defic Syndr Date: 2012-08-15 Impact factor: 3.731
Authors: Xiangrong Kong; Godfrey Kigozi; Joseph Ssekasanvu; Fred Nalugoda; Gertrude Nakigozi; Anthony Ndyanabo; Tom Lutalo; Steven J Reynolds; Robert Ssekubugu; Joseph Kagaayi; Eva Bugos; Larry W Chang; Pilgrim Nanlesta; Grabowski Mary; Amanda Berman; Thomas C Quinn; David Serwadda; Maria J Wawer; Ronald H Gray Journal: JAMA Date: 2016-07-12 Impact factor: 56.272